ArticleAdvanced healthcare materials2026
Spatiotemporally Programmed Nanofiber Scaffold for Coordinated Hierarchical Multi-Tissue Regeneration in Pressure Ulcers.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Stage IV pressure ulcers (PUs) represent the most severe form of chronic wounds, involving full-thickness damage to skin, vasculature, nerves, and muscle, and remain difficult to treat due to the need for coordinated multi-tissue regeneration. Here, we develop a nanofiber scaffold that orchestrates multimodal tissue repair through the integration of biophysical guidance and spatiotemporally controlled biochemical signaling. The scaffold features a sandwich-structured architecture composed of poly(ε-caprolactone) (PCL) nanofibrous layers with distinct functions. A radially aligned, wound-facing layer is functionalized with a center-increasing gradient of keratinocyte growth factor 2-loaded collagen nanoparticles, enabling rapid diffusion-driven delivery to accelerate early re-epithelialization. The outer layer comprises randomly oriented PCL nanofibers, ensuring mechanical support and structural stability. Between these layers, phase-change material microparticles co-encapsulating basic fibroblast growth factor and indocyanine green enable near-infrared-triggered, on-demand release, sustaining local bFGF availability to support vascular reconstruction and subsequent muscle regeneration. This temporally coordinated delivery strategy couples early-stage epidermal repair with prolonged support for deeper tissue regeneration. In a rat stage IV PU model, the scaffold accelerates wound closure and promotes coordinated regeneration of multiple tissue components, outperforming clinically used wound dressings. Collectively, this work establishes a nanofiber-based strategy for spatiotemporally orchestrated tissue regeneration in severe wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.